News & Resources

Press Release

Printer Friendly Version View printer-friendly version
<< Back
Orexigen Therapeutics to Provide Business Update and Discuss First Quarter 2017 Financial Results on May 9, 2017

SAN DIEGO, April 25, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (NASDAQ: OREX) will announce corporate and financial results for the first quarter 2017 on Tuesday, May 9th after the market closes. Following the announcement, Orexigen will provide a business update and discuss the financial results in a live webcast and conference call at 5:00 p.m. Eastern Daylight Time (2:00 p.m. Pacific Daylight Time).

The live call may be accessed by phone by calling (800) 708-4540 (domestic) or (847) 619-6397 (international), participant code 44748374. The webcast can be accessed live on the "Investors" section of the Orexigen web site at, and will be archived for 14 days following the call.

Orexigen Contact:

Jason Keyes
Chief Financial Officer
Orexigen Therapeutics, Inc.

Media Contact:
Erika Hackmann


To view the original version on PR Newswire, visit:

SOURCE Orexigen Therapeutics, Inc.